Evidence map›Paper›PMID 40926332›Full record

ArticleAlcohol, clinical & experimental research2025

Targeting G9a decreases escalated alcohol drinking in male mice in a model of combined stress and chronic alcohol exposure.

Marcelo F Lopez, Paulina Misztak, Howard C Becker, Christopher W Cowan, Ethan M Anderson

Abstract read
In one paragraph

Article in Alcohol, clinical & experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marcelo F LopezDepartment of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID https://orcid.org/0000-0001-5885-7371
Paulina MisztakDepartment of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, Louisiana, USA.
Howard C BeckerDepartment of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID https://orcid.org/0000-0001-8042-6957
Christopher W CowanDepartment of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA.
Ethan M AndersonDepartment of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID https://orcid.org/0000-0002-4021-6741

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Patrick J. Mulholland · 1996 to 2026
$46.8M
Ethanol Dependence &Stress Effects on Ethanol DrinkingU01AA014095 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWARD C. BECKER · 2003 to 2026
$9.0M
Role of Class IIa HDAC Target Genes in Opioid and Cocaine AddictionR01DA032708 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI COWAN, CHRISTOPHER W · 2013 to 2022
$3.8M
Stress and Ethanol Dependence: SK Channels and GlutamateU01AA020930 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MULHOLLAND, PATRICK J. · 2012 to 2021
$2.6M
CORE 2/2: INIA Stress and Chronic Alcohol Interactions: CIE-Stress Mouse Brain Activity Mapping Core (BAMC)U24AA029968 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Marcelo F. Lopez, Patrick J. Mulholland · 2022 to 2026
$2.0M
Mouse Chronic Intermittent Ethanol (CIE) CoreU01AA020929 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LOPEZ, MARCELO F. · 2012 to 2015
$1.5M
Mouse Chronic Intermittent Ethanol (CIE) CoreU24AA020929 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LOPEZ, MARCELO F. · 2016 to 2021
$1.1M
Targeting Phospholipase C and Dendritic Spines to Reduce Cocaine and Heroin MotivationK01DA046513 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ANDERSON, ETHAN MICHAEL · 2019 to 2023
$943k
Epigenetic regulation of stress-potentiated ethanol drinkingR01AA031007 · NIAAA · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI Ethan Michael Anderson · 2025 to 2026
$795k
Development of novel pharmacotherapies for AUDR41AA029365 · NIAAA · NEUROEPIGENIX, LLC · PI ANDERSON, ETHAN MICHAEL, COWAN, CHRISTOPHER W · 2022 to 2022
$393k
BLRD VA IK6 BX006299NIAAA NIH HHS P50 AA010761NIAAA NIH HHS P50 AA10761NIAAA NIH HHS R01 AA031007NIAAA NIH HHS R01AA031007NIAAA NIH HHS R41 AA029365NIAAA NIH HHS U01 AA014095NIAAA NIH HHS U01 AA020929NIAAA NIH HHS U01 AA020930NIAAA NIH HHS U24 AA020929NIAAA NIH HHS U24 AA029968NIAAA NIH HHS U29 AA020929NIDA NIH HHS K01 DA046513NIDA NIH HHS R01 DA032708
6 · The paper itself

Abstract

backgroundAlcohol use disorder (AUD) is a pervasive problem in society afflicting millions of people worldwide. One reason for the prevalence of AUD is that heavy alcohol drinking can produce alcohol dependence. In addition, alcohol dependence dysregulates the body's stress systems to increase alcohol drinking. Therefore, targeting dependence- and/or stress-related alcohol drinking clinically could reduce heavy drinking in patients with AUD. One key mechanism thought to contribute to behaviors associated with AUD is long-lasting epigenetic alterations of gene expression. We recently showed that the epigenetic regulatory enzyme G9a (also known as euchromatic histone-lysine N-methyltransferase 2 or EHMT2) is downregulated in the nucleus accumbens (NAc) in mice by alcohol dependence produced by the chronic intermittent alcohol (CIE) model. Also, we showed that either viral-mediated NAc G9a knockdown or a systemically administered G9a inhibitor reduced stress-potentiated alcohol drinking by the kappa-opioid agonist U50,488.

methodsHere, we tested whether NAc G9a knockdown reduces escalated alcohol drinking in a mouse model of combined dependence plus forced swim stress (CIE + FSS) in male mice. We also tested for changes in sucrose drinking, sucrose preference, and water consumption as controls. In addition, we tested whether systemic administration of a G9a inhibitor, UNC0642, could reduce alcohol drinking in the CIE + FSS model.

resultsWe found that either NAc G9a knockdown or repeated systemic UNC0642 administration reduced escalated ethanol drinking following CIE + FSS, but without altering control levels of ethanol drinking or sucrose drinking or water drinking in male mice.

conclusionsThese preclinical data suggest that reducing NAc G9a levels, or suppressing its enzymatic activity, can effectively reduce potentiated alcohol drinking produced by stress and/or alcohol dependence. These data suggest that G9a inhibition holds promise as a potential therapeutic for individuals who suffer from AUD.

Indexed as

Alcohol DrinkingAlcoholismHistone-Lysine N-MethyltransferaseStress, PsychologicalAnimalsDisease Models, AnimalEthanolGene Knockdown TechniquesMaleMiceMice, Inbred C57BLNucleus AccumbensEthanolG9a protein, mouseHistone-Lysine N-Methyltransferaseaccumbensdependenceepigenetickappa‐opioid receptortherapeutics

Identifiers

PMID40926332
PMCPMC12519044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.